Yorktown Management & Research Company’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-480
| Closed | -$284K | – | 219 |
|
2022
Q2 | $284K | Hold |
480
| – | – | 0.37% | 124 |
|
2022
Q1 | $335K | Hold |
480
| – | – | 0.28% | 141 |
|
2021
Q4 | $303K | Hold |
480
| – | – | 0.2% | 183 |
|
2021
Q3 | $290K | Hold |
480
| – | – | 0.22% | 181 |
|
2021
Q2 | $268K | Buy |
+480
| New | +$268K | 0.21% | 200 |
|
2020
Q4 | – | Sell |
-500
| Closed | -$280K | – | 250 |
|
2020
Q3 | $280K | Hold |
500
| – | – | 0.26% | 210 |
|
2020
Q2 | $312K | Hold |
500
| – | – | 0.28% | 169 |
|
2020
Q1 | $244K | Sell |
500
-650
| -57% | -$317K | 0.25% | 169 |
|
2019
Q4 | $432K | Buy |
+1,150
| New | +$432K | 0.23% | 139 |
|
2019
Q2 | – | Sell |
-700
| Closed | -$287K | – | 349 |
|
2019
Q1 | $287K | Hold |
700
| – | – | 0.09% | 261 |
|
2018
Q4 | $261K | Hold |
700
| – | – | 0.09% | 265 |
|
2018
Q3 | $283K | Hold |
700
| – | – | 0.08% | 306 |
|
2018
Q2 | $241K | Hold |
700
| – | – | 0.07% | 323 |
|
2018
Q1 | $241K | Hold |
700
| – | – | 0.07% | 337 |
|
2017
Q4 | $263K | Hold |
700
| – | – | 0.08% | 327 |
|
2017
Q3 | $313K | Hold |
700
| – | – | 0.08% | 230 |
|
2017
Q2 | $344K | Hold |
700
| – | – | 0.11% | 103 |
|
2017
Q1 | $271K | Hold |
700
| – | – | 0.07% | 214 |
|
2016
Q4 | $257K | Hold |
700
| – | – | 0.07% | 229 |
|
2016
Q3 | $281K | Hold |
700
| – | – | 0.06% | 184 |
|
2016
Q2 | $244K | Hold |
700
| – | – | 0.06% | 232 |
|
2016
Q1 | $252K | Hold |
700
| – | – | 0.05% | 274 |
|
2015
Q4 | $380K | Hold |
700
| – | – | 0.07% | 184 |
|
2015
Q3 | $326K | Hold |
700
| – | – | 0.05% | 221 |
|
2015
Q2 | $357K | Hold |
700
| – | – | 0.06% | 175 |
|
2015
Q1 | $316K | Hold |
700
| – | – | 0.06% | 192 |
|
2014
Q4 | $287K | Buy |
+700
| New | +$287K | 0.06% | 184 |
|